BRCA1/2mut tumors have been predicted to contain more neoantigens than tumors with no alterations in genes of the HR pathway (HRwt)6, harbor an increased number of tumor-infiltrating lymphocytes6, and have an elevated PD-L1 expression as compared to HR-proficient tumors6,8. The gene discussed is CD274; the disease is neoplasm.